4.4 Article

TRPM4 channels in the cardiovascular system

Journal

CURRENT OPINION IN PHARMACOLOGY
Volume 15, Issue -, Pages 68-73

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2013.12.003

Keywords

-

Funding

  1. Alexander von Humboldt-Foundation (Feodor Lynen Fellowship)
  2. National Institutes of Health [R01 NS08174]
  3. Deutsche Forschungsgemeinschaft [Po137/41-1]
  4. Hertie-Foundation [P2040097]

Ask authors/readers for more resources

The non-selective Transient Receptor Potential Melastatin 4 (TRPM4) cation channel is abundantly expressed in cardiac cells, being involved in several aspects of cardiac rhythmicity, including cardiac conduction, pace making and action-potential repolarization. Dominantly inherited mutations in the TRPM4 gene are associated with the cardiac bundle-branch disorder progressive familial heart block type I (PFHBI) and isolated cardiac conduction disease (ICCD) giving rise to atrio-ventricular conduction block (AVB), right bundle branch block, bradycardia, and the Brugada syndrome. The mutant phenotypes closely resemble those associated with mutations in the SCN5A gene, encoding the voltage-gated Na+ channel Na(v)1.5. These observations and the unexpected partnership with sulfonylurea-receptors (SURs) makes the TRPM4 channel a promising novel target for treatment of cardiac disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available